Literature DB >> 31222441

Is there a benefit to additional neuroaxial anesthesia in open nephrectomy? A prospective NSQIP propensity score analysis.

Amr Mahran1,2, Kirtishri Mishra2, Danly Omil-Lima2, Bissan Abboud2, Michael Wang1,2, Jason Jankowski2,3, Robert Abouassaly4,5, Lee Ponsky2,3, Irma Lengu6, Laura Bukavina7.   

Abstract

INTRODUCTION: Neuroaxial (i.e., spinal, regional, epidural) anesthesia has been shown to be associated with reduced readmission rate, decreased hospital stay, and decreased overall complication rate in orthopedic and gynecologic surgery. Our aim was to identify differences in intra- and postoperative complications, length of stay and readmission rates in open nephrectomy patients managed with neuroaxial anesthesia.
MATERIALS AND METHODS: Utilizing National Surgical Quality Inpatient Program (NSQIP) database, we identified patients who have undergone an open nephrectomy between 2014 and 2017. Patients were further subdivided based on anesthesia modality. We used the propensity score-matching (PSM) method to adjust for baseline differences among patients who received general anesthesia alone and those with additional neuroaxial anesthesia. Using step-wise multivariable logistic regression, we identified preoperative and intraoperative predictors associated with 30-day procedure-related readmission, complications, and postoperative length of stay.
RESULTS: Out of 3,633 patients identified, 2346 patients met our inclusion and exclusion criteria. There was no difference in baseline characteristics after propensity score matching between general and additional neuroaxial anesthesia. Postoperative outcomes including: procedure-related readmission, rate of reoperation, operative time, all complications were similar between the groups. Adjuvant neuroaxial anesthesia group did experience a prolonged postoperative hospital stay that was statistically significant as compared to patients with general anesthesia alone [5.3 (3.5) days vs 4.8 (2.9) days, p = 0.007]. Compared to GA alone after multivariable logistic regression, neuroaxial anesthesia was not statistically significant for readmission (p = 0.909), any complication (p = 0.505), but did showed increased odds ratio of prolonged postoperative stay [aOR 1.107, 95% CI 1.042-1.176, p = 0.001] after adjusting for multiple factors.
CONCLUSION: Using 2014-2017 NSQIP database, we were able to demonstrate no additional reduction in complication or readmission rate in patients with neuroaxial anesthesia as compared to general anesthesia alone. Furthermore, patients who did receive neuroaxial anesthesia experienced a longer postoperative course.

Entities:  

Keywords:  Kidney cancer; Neuroaxial anesthesia; Renal cell

Mesh:

Year:  2019        PMID: 31222441     DOI: 10.1007/s11255-019-02208-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

1.  Continuous spinal anaesthesia/analgesia for the perioperative management of high-risk patients.

Authors:  D Michaloudis; A Petrou; P Bakos; A Chatzimichali; K Kafkalaki; A Papaioannou; M Zeaki; A Flossos
Journal:  Eur J Anaesthesiol       Date:  2000-04       Impact factor: 4.330

2.  Spinal analgesia for laparoscopic colonic resection using an enhanced recovery after surgery programme: better analgesia, but no benefits on postoperative recovery: a randomized controlled trial.

Authors:  M Wongyingsinn; G Baldini; B Stein; P Charlebois; S Liberman; F Carli
Journal:  Br J Anaesth       Date:  2012-03-08       Impact factor: 9.166

3.  Intravenous lidocaine versus thoracic epidural analgesia: a randomized controlled trial in patients undergoing laparoscopic colorectal surgery using an enhanced recovery program.

Authors:  Mingkwan Wongyingsinn; Gabriele Baldini; Patrick Charlebois; Sender Liberman; Barry Stein; Franco Carli
Journal:  Reg Anesth Pain Med       Date:  2011 May-Jun       Impact factor: 6.288

4.  Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Mira Shiloach; Stanley K Frencher; Janet E Steeger; Katherine S Rowell; Kristine Bartzokis; Majed G Tomeh; Karen E Richards; Clifford Y Ko; Bruce L Hall
Journal:  J Am Coll Surg       Date:  2009-11-22       Impact factor: 6.113

5.  Results of endovascular aortic aneurysm repair with general, regional, and local/monitored anesthesia care in the American College of Surgeons National Surgical Quality Improvement Program database.

Authors:  Matthew S Edwards; Jeanette S Andrews; Angela F Edwards; Racheed J Ghanami; Matthew A Corriere; Philip P Goodney; Christopher J Godshall; Kimberley J Hansen
Journal:  J Vasc Surg       Date:  2011-07-01       Impact factor: 4.268

6.  Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults.

Authors:  Mark D Neuman; Jeffrey H Silber; Nabil M Elkassabany; Justin M Ludwig; Lee A Fleisher
Journal:  Anesthesiology       Date:  2012-07       Impact factor: 7.892

7.  Perioperative comparative effectiveness of anesthetic technique in orthopedic patients.

Authors:  Stavros G Memtsoudis; Xuming Sun; Ya-Lin Chiu; Ottokar Stundner; Spencer S Liu; Samprit Banerjee; Madhu Mazumdar; Nigel E Sharrock
Journal:  Anesthesiology       Date:  2013-05       Impact factor: 7.892

Review 8.  Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review.

Authors:  Pasqualina L Santaguida; Gillian A Hawker; Pamela L Hudak; Richard Glazier; Nizar N Mahomed; Hans J Kreder; Peter C Coyte; James G Wright
Journal:  Can J Surg       Date:  2008-12       Impact factor: 2.089

9.  Differences in short-term complications between spinal and general anesthesia for primary total knee arthroplasty.

Authors:  Andrew J Pugely; Christopher T Martin; Yubo Gao; Sergio Mendoza-Lattes; John J Callaghan
Journal:  J Bone Joint Surg Am       Date:  2013-02-06       Impact factor: 5.284

10.  Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011.

Authors:  Li Hui Chen; Holly Hedegaard; Margaret Warner
Journal:  NCHS Data Brief       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.